{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:03:49Z","timestamp":1789362229071,"version":"build-2803163510"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.euroneuro.2026.112908","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:47:36Z","timestamp":1783064856000},"page":"112908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD"],"prefix":"10.1016","volume":"112","author":[{"given":"Cleo L.","family":"Crunelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-4471","authenticated-orcid":false,"given":"Michiel W.","family":"Van Kernebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6364-9136","authenticated-orcid":false,"given":"Mathias","family":"Luderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2026.112908_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2026.112783","article-title":"Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit\/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)","volume":"106","author":"Brynte","year":"2026","journal-title":"European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2026.112908_bib0002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000487767","article-title":"International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit\/Hyperactivity Disorder","volume":"24","author":"Crunelle","year":"2018","journal-title":"European addiction research"},{"key":"10.1016\/j.euroneuro.2026.112908_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2026.112863","article-title":"The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD","volume":"111","author":"Goodman","year":"2026","journal-title":"European neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2026.112908_bib0004","article-title":"Stigma from healthcare professionals and care-limiting behaviors in individuals with substance use disorders: a mixed-methods study","volume":"63","author":"Luderer","year":"2026","journal-title":"Lancet Reg Health Eur"},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112908_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.9492","article-title":"Safety of Stimulants Across Patient Populations: A Meta-Analysis","volume":"8","author":"Oliva","year":"2025","journal-title":"JAMA network open,"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X26001495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X26001495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:26:30Z","timestamp":1789359990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X26001495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":5,"alternative-id":["S0924977X26001495"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112908","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. and ECNP. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112908"}}